title: The role of 18F-FDG PET/CT in the evaluation of solid splenic masses.
abstract: 18F-Fluorodeoxyglucose-positron emission tomography/computed tomography is a noninvasive imaging modality that appears to have a high negative-predictive value for malignancy in assessing solid splenic masses discovered on conventional imaging modalities. Histological sampling is recommended for fluorodeoxyglucose-avid splenic masses, as the main differential diagnosis includes malignancy, either primary or secondary, or granulomatous disease.
authors.affiliation: Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. umetser@tasmc.health.gov.il
authors.forename: Ur
authors.initials: U
authors.lastname: Metser
authors.forename: Einat
authors.initials: E
authors.lastname: Even-Sapir
mesh_terms: D003937:Diagnosis, Differential; D019788:Fluorodeoxyglucose F18; D006801:Humans; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D013160:Splenic Neoplasms / Q000000981:diagnostic imaging*; D014057:Tomography, X-Ray Computed / Q000379:methods*
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18